Journal of Surgical Oncology. 2009 Jan 1;99(1):51-7. [Link]
RodrÃguez D, Cheung MC, Housri N, Koniaris LG.
Division of Surgical Oncology, DeWitt Daughtry Family Department of Surgery, University of Miami Miller School of Medicine, Miami, FL 33136, USA.
Objective: Determine the role of surgery for patients with malignant abdominal mesotheliomas (MAMs).
Methods: The Surveillance, Epidemiology, and End Results (SEER) database (1973-2005) was queried.
Results: Overall, 10,589 cases of malignant mesotheliomas were identified. Of these, 9,211 cases were thoracic (TM) and 1,112 cases were MAM (10.5%). Patients with TM presented with more localized disease than those patients with MAM (P < 0.001). MAM more often affected younger patients (63 years vs. 71 years) (P < 0.001). The annual incidence of MAM was approximately 1.00 case per 100,000 in 2005. Overall median survival for MAM patients was 8 months, with a significant difference between women and men (13 months vs. 6 months, respectively) (P < 0.001). Patients who successfully underwent surgical resection had a considerably longer median survival (20 months vs. 4 months, P < 0.001) as well as a significantly higher 5-year survival (28% vs. 12%, P < 0.001). Multivariate analysis identified that a poorly differentiated tumor grade, failure to undertake surgical resection, advanced age, and male gender were all independent predictors of poorer outcome.
Conclusion: Surgical extirpation of MAM may be associated with significantly improved survival. All patients with MAM should be evaluated for potential surgical resection.
Keywords: malignancy, cancer, survival, surgery, peritoneal mesothelioma, thoracic mesothelioma, pleural mesothelioma, SEER, abdominal mesothelioma, outcomes